The weekly litigation news digest is live. Subscribe now

IP Verse

Long Lasting Effect Of New Botulinum Toxin Formulations - EP3079714

The patent EP3079714 was granted to Medy TOX on Nov 25, 2020. The application was filed on Dec 12, 2014 under application number EP14815207A. The patent is currently recorded with a legal status of "Revoked".

EP3079714

MEDY TOX
Application Number
EP14815207A
Filing Date
Dec 12, 2014
Status
Revoked
Nov 25, 2022
Publication Date
Nov 25, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
GALDERMA HOLDINGAug 24, 2021PLASSERAUDADMISSIBLE

Patent Citations (7) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTEP2692350
INTERNATIONAL-SEARCH-REPORTUS2003118598
INTERNATIONAL-SEARCH-REPORTUS2006018931
INTERNATIONAL-SEARCH-REPORTWO2007044809
INTERNATIONAL-SEARCH-REPORTWO2009008595
INTERNATIONAL-SEARCH-REPORTWO2012048854
OPPOSITIONWO2012134240

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents